Ontology highlight
ABSTRACT:
SUBMITTER: Kovalevsky AY
PROVIDER: S-EPMC3015180 | biostudies-other | 2006 Feb
REPOSITORIES: biostudies-other
Kovalevsky Andrey Yu AY Tie Yunfeng Y Liu Fengling F Boross Peter I PI Wang Yuan-Fang YF Leshchenko Sofiya S Ghosh Arun K AK Harrison Robert W RW Weber Irene T IT
Journal of medicinal chemistry 20060201 4
The potent new antiviral inhibitor TMC-114 (UIC-94017) of HIV-1 protease (PR) has been studied with three PR variants containing single mutations D30N, I50V, and L90M, which provide resistance to the major clinical inhibitors. The inhibition constants (K(i)) of TMC-114 for mutants PR(D30N), PR(I50V), and PR(L90M) were 30-, 9-, and 0.14-fold, respectively, relative to wild-type PR. The molecular basis for the inhibition was analyzed using high-resolution (1.22-1.45 A) crystal structures of PR mut ...[more]